Malgorzata Gozdecka
Wellcome/MRC Cambridge Stem Cell Institute(GB)University of Cambridge(GB)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Genomics and Chromatin Dynamics, Epigenetics and DNA Methylation, CRISPR and Genetic Engineering
Most-Cited Works
- → Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia(2021)1,281 cited
- → A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia(2016)815 cited
- → UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs(2018)166 cited
- → Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice(2009)128 cited
- → Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML(2019)120 cited
- → SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4(2018)88 cited
- → The roles of ATF2 (activating transcription factor 2) in tumorigenesis(2012)84 cited
- → KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements(2020)51 cited
- → JNK Suppresses Tumor Formation via a Gene-Expression Program Mediated by ATF2(2014)48 cited
- → Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression(2021)36 cited